New research tracks how cells prepare gene regulatory decisions that will define their fate during the earliest stages of ...
The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...
Scientists have identified a 14-protein blood signature that may predict lung cancer risk more than five years before ...
While genomics remains foundational, proteomics is offering a deeper understanding of the molecules that drive cancer.
WARREN, N.J., June 09, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today ...
Discusses Clinical Data and Updated Development Strategy for Darlifarnib June 3, 2026 3:15 PM EDTCompany ParticipantsTroy ...
At ASCO, Dr Shubham Pant discussed trial results showing Daraxonrasib improved outcomes in advanced pancreatic cancer. He ...
Telangana IT and Industries Minister D Sridhar Babu inaugurated the Rs 1,200-crore TheraNym Biologics facility in Sangareddy, ...
Bhubaneswar: In a major step towards advancing sustainable urban mobility and accelerating Odisha's transition to clean ...
MEDIPOST, a fully integrated commercial stage cell therapy biotechnology company, announced today that it has secured the FDA ...
M42, a global health leader powered by technology, artificial intelligence, and genomics, and Arcera Life Sciences, a global ...
Celularity Inc. (Nasdaq: CELU) ('Celularity”), a longevity-focused regenerative and cellular medicine company pioneering placental-derived cellular therapies, and Fountain Life Management, LLC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results